Functional studies showed that miR-1224-5p suppresses tumour metastasis by targeting FAK in intestinal-type gastric cancer, and inhibits the proliferation and invasion of glioma cells by targeting CREB1 (refs. 9,22). This evidence concerns the gene CREB1 and neoplasm.